Literature DB >> 24995848

Low coverage and acceptable effectiveness of single dose of Japanese encephalitis vaccine, Gorakhpur division, Uttar Pradesh, India, 2013.

Manoj V Murhekar1, Prashant Ranjan2, Sriram Selvaraju2, Ashok Pandey3, Milind M Gore3, Sanjay M Mehendale2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24995848     DOI： 10.1016/j.jinf.2014.06.017

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  6 in total

Review 1.  Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.

Authors:  Nagendra R Hegde; Milind M Gore
Journal:  Hum Vaccin Immunother       Date:  2017-02-22       Impact factor: 3.452

2.  Effectiveness of introduction of JEV vaccination into routine immunization program in a tribal district of Odisha.

Authors:  Jaya S Kshatri; Matrujyoti Pattnaik; Goldi Badaik; Hari R Choudhary; Asit Mansingh; Sanghamitra Pati; Debdutta Bhattacharya
Journal:  J Family Med Prim Care       Date:  2022-05-14

3.  Coverage & missed opportunity for Japanese encephalitis vaccine, Gorakhpur division, Uttar Pradesh, India, 2015: Implications for Japanese encephalitis control.

Authors:  Manoj V Murhekar; Chinmay Oak; Prashant Ranjan; K Kanagasabai; Satish Shinde; Ashok Kumar Pandey; Mahima Mittal; Milind Gore; Sanjay M Mehendale
Journal:  Indian J Med Res       Date:  2017-01       Impact factor: 2.375

4.  Emergence of Orientia tsutsugamushi as an important cause of Acute Encephalitis Syndrome in India.

Authors:  Parul Jain; Shantanu Prakash; Piyush K Tripathi; Archana Chauhan; Shikha Gupta; Umesh Sharma; Anil K Jaiswal; Devraj Sharma; Amita Jain
Journal:  PLoS Negl Trop Dis       Date:  2018-03-28

5.  Antibody persistence and immune memory response following primary vaccination and boosting with live attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) in Bangladesh: A phase 4 open-label clinical trial.

Authors:  K Zaman; Md Yunus; Asma B Aziz; Jodi Feser; Jessica Mooney; Yuxiao Tang; Damon W Ellison; Butsaya Thaisomboonsuk; Lei Zhang; Kathleen M Neuzil; Anthony A Marfin; G William Letson
Journal:  Vaccine X       Date:  2022-02-05

6.  The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control.

Authors:  Kirsten S Vannice; Susan L Hills; Lauren M Schwartz; Alan D Barrett; James Heffelfinger; Joachim Hombach; G William Letson; Tom Solomon; Anthony A Marfin
Journal:  NPJ Vaccines       Date:  2021-06-15       Impact factor: 7.344
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.